New 'vaccine style' treatment shows promise for slowing Parkinson's
Date
Research news
Date
The full results show that exenatide had no benefits over the placebo and didn’t slow the progression of Parkinson’s.
Date
The government has announced plans to reform elective (planned) health care in England to reduce waiting lists and give patients more choice, but more is needed for people with Parkinson’s.
Date
A small study of a drug called propranolol looked effective in easing tremor both at rest and in stressful situations for people with Parkinson’s.
Date
We're disappointed that Lecigon, a new treatment for advanced Parkinson's, has been rejected by NHS Scotland. We're increasingly concerned about access to advanced treatments in Scotland.
Date
Following the Neurological Alliance's #BackThe1in6 campaign, which Parkinson's UK supported, the UK government has launched the first ever forum to address gaps in treatment and care for people affected by neurological conditions.
Date
Earlier this week we brought together healthcare professionals, charities, people with Parkinson's and senior Scottish government officials for a summit in Edinburgh on time critical medication.
Date
The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.
Date
Parkinson’s UK has granted funding to projects aiming to advance our understanding of the causes and symptoms of Parkinson’s, as well as exploring new treatments.
Date
The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.